BlossomHill Therapeutics, Inc. (BLSM) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−9.1x

Market Cap

$674.47M

MomentumView details →

1D Return

+9.94%

YTD Return

—

RSI (14)

71.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−9.1x

Market Cap

$674.47M

RSI (14)

71.3

MomentumView details →

1D Return

+9.94%

YTD Return

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

39.81%

ROA (TTM)

−42.23%

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

−96.23%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$0.90

EPS Surprise

2.81%

Beats (12Q)

1/12

Next Q EPS Est

−$0.87

Avg Surprise (4Q)

2.81%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

−0.15x

Current Ratio

7.40x

Quick Ratio

7.40x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

No recent news for BLSM.

Similar companies

Brii Biosciences Limited02137.HK Prime Medicine, Inc.PRME Sagimet Biosciences Inc.SGMT Allogene Therapeutics, Inc.ALLO Shattuck Labs, Inc.STTK MiMedx Group, Inc.MDXG Find similar companies →

Latest newsMore news →

No recent news for BLSM.